Wang QM - Search Results

1

P4 cap modified tetrapeptidyl alpha-ketoamides as potent HCV NS3 protease inhibitors.

Sun DX, Liu L, Heinz B, Kolykhalov A, Lamar J, Johnson RB, Wang QM, Yip Y, Chen SH. Sun DX, et al. Among authors: wang qm. Bioorg Med Chem Lett. 2004 Aug 16;14(16):4333-8. doi: 10.1016/j.bmcl.2004.05.078. Bioorg Med Chem Lett. 2004. PMID: 15261297

2

Synthesis and evaluation of tripeptidyl alpha-ketoamides as human rhinovirus 3C protease inhibitors.

Chen SH, Lamar J, Victor F, Snyder N, Johnson R, Heinz BA, Wakulchik M, Wang QM. Chen SH, et al. Among authors: wang qm. Bioorg Med Chem Lett. 2003 Oct 20;13(20):3531-6. doi: 10.1016/s0960-894x(03)00753-4. Bioorg Med Chem Lett. 2003. PMID: 14505664

3

Discovery of a novel bicycloproline P2 bearing peptidyl alpha-ketoamide LY514962 as HCV protease inhibitor.

Yip Y, Victor F, Lamar J, Johnson R, Wang QM, Barket D, Glass J, Jin L, Liu L, Venable D, Wakulchik M, Xie C, Heinz B, Villarreal E, Colacino J, Yumibe N, Tebbe M, Munroe J, Chen SH. Yip Y, et al. Among authors: wang qm. Bioorg Med Chem Lett. 2004 Jan 5;14(1):251-6. doi: 10.1016/j.bmcl.2003.09.074. Bioorg Med Chem Lett. 2004. PMID: 14684337

4

P1 and P3 optimization of novel bicycloproline P2 bearing tetrapeptidyl alpha-ketoamide based HCV protease inhibitors.

Victor F, Lamar J, Snyder N, Yip Y, Guo D, Yumibe N, Johnson RB, Wang QM, Glass JI, Chen SH. Victor F, et al. Among authors: wang qm. Bioorg Med Chem Lett. 2004 Jan 5;14(1):257-61. doi: 10.1016/j.bmcl.2003.09.075. Bioorg Med Chem Lett. 2004. PMID: 14684338

5

Novel P4 truncated tripeptidyl alpha-ketoamides as HCV protease inhibitors.

Lamar J, Victor F, Snyder N, Johnson RB, Wang QM, Glass JI, Chen SH. Lamar J, et al. Among authors: wang qm. Bioorg Med Chem Lett. 2004 Jan 5;14(1):263-6. doi: 10.1016/j.bmcl.2003.09.076. Bioorg Med Chem Lett. 2004. PMID: 14684339

6

P4 and P1' optimization of bicycloproline P2 bearing tetrapeptidyl alpha-ketoamides as HCV protease inhibitors.

Yip Y, Victor F, Lamar J, Johnson R, Wang QM, Glass JI, Yumibe N, Wakulchik M, Munroe J, Chen SH. Yip Y, et al. Among authors: wang qm. Bioorg Med Chem Lett. 2004 Oct 4;14(19):5007-11. doi: 10.1016/j.bmcl.2004.07.007. Bioorg Med Chem Lett. 2004. PMID: 15341970

7

Activation of human rhinovirus-14 3C protease.

Wang QM, Johnson RB. Wang QM, et al. Virology. 2001 Feb 1;280(1):80-6. doi: 10.1006/viro.2000.0760. Virology. 2001. PMID: 11162821 Free article.

8

Recent advances in prevention and treatment of hepatitis C virus infections.

Wang QM, Heinz BA. Wang QM, et al. Prog Drug Res. 2001;Spec No:79-110. doi: 10.1007/978-3-0348-7784-8_3. Prog Drug Res. 2001. PMID: 11548211 Review.

9

Comparative characterization of two DEAD-box RNA helicases in superfamily II: human translation-initiation factor 4A and hepatitis C virus non-structural protein 3 (NS3) helicase.

Du MX, Johnson RB, Sun XL, Staschke KA, Colacino J, Wang QM. Du MX, et al. Among authors: wang qm. Biochem J. 2002 Apr 1;363(Pt 1):147-55. doi: 10.1042/0264-6021:3630147. Biochem J. 2002. PMID: 11903057 Free PMC article.

10

Identification of a C-terminal regulatory motif in hepatitis C virus RNA-dependent RNA polymerase: structural and biochemical analysis.

Lévêque VJ, Johnson RB, Parsons S, Ren J, Xie C, Zhang F, Wang QM. Lévêque VJ, et al. Among authors: wang qm. J Virol. 2003 Aug;77(16):9020-8. doi: 10.1128/jvi.77.16.9020-9028.2003. J Virol. 2003. PMID: 12885918 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

737 results

Search Page

Filters